Lung Carcinoma — Research

Lung Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	273,384	`("Lung Carcinoma"[tiab] OR "Lung Cancer"[tiab] OR "Carcinoma of Lung"[tiab] OR "Carcinoma of the Lung"[tiab] OR "Lung Cancer all types"[tiab])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	94,693	`("Lung Carcinoma"[tiab] OR "Lung Cancer"[tiab] OR "Carcinoma of Lung"[tiab] OR "Carcinoma of the Lung"[tiab] OR "Lung Cancer all types"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	19,676	`("Lung Carcinoma"[tiab] OR "Lung Cancer"[tiab] OR "Carcinoma of Lung"[tiab] OR "Carcinoma of the Lung"[tiab] OR "Lung Cancer all types"[tiab]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 21 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (381)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 226–250 of 381 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies.
· J Thorac Oncol · 2020 · PMID 31988000 · validated civic_curation pubmed
EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.
· Cancer Discov · 2016 · PMID 27102076 · validated civic_curation pubmed
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib.
· Front Oncol · 2022 · PMID 36419889 · validated civic_curation pubmed
EGFR-RAD51 fusion variant in lung adenocarcinoma and response to erlotinib: A case report.
· Lung Cancer · 2018 · PMID 29290255